7261
Physiology & Medicine / Cannabis
« on: 06/11/2002 22:12:36 »
The following news flash just came up on the doctors.net.uk site - I thought people here might be interested, particularly in view of the MS question asked by another visitor previously...
"A cannabis medicine could be available in Britain next year following the success of trials, it was announced yesterday.
Trials of a cannabis spray have shown that it can reduce pain, spasticity and sleep disturbance.
The drug was compared with a placebo in the trial involving 350 patients, many of them suffering from multiple sclerosis, developer GW Pharmaceuticals said.
The company said it was undertaking a further five sets of phase III trials.
Dr Philip Robson, medical director of GW medical director, said: "The results show statistically significant reductions in neuropathic pain, which is recognised as being difficult to treat and is often particularly distressing.
"There were also significant improvements in other symptoms in patients with MS, notably spasticity and sleep disturbance. "
"A cannabis medicine could be available in Britain next year following the success of trials, it was announced yesterday.
Trials of a cannabis spray have shown that it can reduce pain, spasticity and sleep disturbance.
The drug was compared with a placebo in the trial involving 350 patients, many of them suffering from multiple sclerosis, developer GW Pharmaceuticals said.
The company said it was undertaking a further five sets of phase III trials.
Dr Philip Robson, medical director of GW medical director, said: "The results show statistically significant reductions in neuropathic pain, which is recognised as being difficult to treat and is often particularly distressing.
"There were also significant improvements in other symptoms in patients with MS, notably spasticity and sleep disturbance. "